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Hyperglycemia appears  to be the major risk  factor for the development of 
diabetic microvascular disease (1-3).  However, the sequence of events leading 
from abnormal glucose homeostasis to irreversible tissue damage remains to be 
elucidated. 
Morphologically, diabetic microvascular disease is characterized by thickening 
of capillary basement membranes that  characteristically exhibit intense linear 
immunofluorescent staining for albumin and IgG (4).  The protein attached to 
diabetic kidney extracellular matrix remains bound even after prolonged washing 
with phosphate-buffered saline (PBS),  hypotonic or hypertonic sodium chloride 
buffers, and potassium  thiocyanate (5).  Such persistent renal accumulation of 
albumin, IgG, or other circulating proteins may be the first step in a process of 
in situ formation of immune complexes (6) in diabetic tissues. Experimentally, a 
diabetes-like giomerulonephritis has been induced by this mechanism (7, 8), and 
in diabetic patients, extensive renal deposition of complement membrane-attack 
complexes has recently been described (9). 
The diabetes-associated excessive attachment of glucose to extravascular ma- 
trix proteins such as basement membrane (10) and collagen (1 1) could be the 
biochemical link between persistent hyperglycemia, excessive high affinity bind- 
ing of plasma constituents, and immunologically mediated tissue damage initiated 
by  the  in  situ  formation  of immune  complexes.  The  initial,  rapidly  formed 
ketoamine products  of nonenzymatic protein  glycosylation, which  have  been 
well-characterized in a variety of diabetic tissue components (12-14),  undergo, 
over time, a variety of degradations, dehydrations, and rearrangements to form 
nonenzymatic browning pigments that  have  highly reactive carbonyl groups. 
Through these carbonyls, late glycosylation products become capable of reacting 
with additional amino groups on other proteins to form intermolecular cross- 
links  (15,  16).  Trapping  of plasma  constituents  by such reactive products  of 
nonenzymatic glycosylation could result  in  the extravascular diabetic  protein 
accumulation described above. Subsequently, some of these tightly bound pro- 
teins could function as planted antibodies or antigens in the in situ formation of 
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immune complexes (6), leading ultimately to diabetic tissue damage. 
In this report,  we have tested this hypothesis, using nonenzymatically glyco- 
sylated collagen.  Binding  of both  albumin  and  IgG  averaged  four  times  the 
amount bound to unmodified collagen. Both albumin and IgG bound to nonen- 
zymatically glycosylated collagen  retained  their  ability to  form  immune com- 
plexes in situ with free antibody and antigen, respectively. 
Materials and Methods 
Collagen hnmobilization.  Soluble collagen from calfskin (Elastin Products, Elastin Com- 
pany, Pacific, MO) was immobilized on agarose by a previously described technique (17), 
using Affi-Gel 10 (Bio-Rad Laboratories, Richmond, CA),  rather than CNBr-activated 
resin. The amount of collagen bound to the resin (determined by quantitating total amino 
acids after acid hydrolysis of an aliquot) was 17.2 mg/ml of gel (18). 
Nonenzwnatic  Glycosylation of Immobilized Collagen.  Immobilized collagen (86  mg) was 
washed with 50 ml of 0.5 M phosphate buffer, pH 7.5, and then resuspended in 5 ml of 
buffer to which ~glucose was added to a final concentration of 500 mM. The immobilized 
collagen samples were incubated with glucose at 37°C. After 10 d, the gels were washed 
with 200 ml of PBS and the samples were then stored at 4°C. Unmodified immobilized 
collagen was prepared by incubating and washing as described without added glucose. All 
solutions contained 3 mM NAN3. 
Radioiodination  of Proteins.  Bovine serum albumin (BSA; Sigma Chemical Company, 
St.  Louis, MO) and rabbit anti-BSA IgG (Miles Laboratories, Elkhart, IN) purified on 
diethylaminoethyl  (DEAE)-Affi-Gel Blue (Bio-Rad Laboratories) were iodinated with ~25I- 
NaI using the IODOGEN procedure (19). Specific activities of BSA and IgG were 507,000 
cpm/nmol and  492,000  cpm/nmol, respectively. Samples were counted in a  Packard 
Tricarb Scintillation Counter (Model 3002; Packard Instrument Co. Inc., United Tech- 
nologies, Downers Grove, IL) and protein was determined by the Bradford method (20). 
Binding of Lysine and Proteins to hnmobilized Collagen.  [14C]L-lysine  (New England Nu- 
125  125  clear, Boston, MA) S.A. 75 cpm/nmol,  I-BSA, and  I-IgG were incubated with both 
unmodified immobilized collagen and nonenzymatically glycosylated collagen (8.6  mg 
of each) at 37°C for 10 d. 20 nmol [14C]lysine  and 1 nmo1125I-labeled protein, respectively, 
were added per milligram of collagen. 
The amount of ligand  bound to immobilized collagen was determined by filtering 
aliquots corresponding to  1 mg of collagen on Durapore hydrophilic membranes (Milli- 
pore, Bedford, MA). Filters were washed six times with 0.5 ml of 0.2 M glycine buffer, 
pH 8.0, followed by six washes of the same buffer containing 2 M NaCI.  Samples con- 
taining ~4C were hydrolyzed with 6 N HCI at 110°C for 12 h and then neutralized before 
addition of hydrofluor scintillation fluid. Samples containing ~I were counted directly. 
Binding of lysine and proteins to agarose alone was assessed under similar conditions. 
No binding of [14C]lysine was detected, and binding of ~I proteins gave blank values of 
2-9 pmol/aliquot. 
In Situ Formation oflmmune Complexes.  Binding of unlabeled proteins to nonenzymati- 
cally glycosylated collagen was accomplished by incubating immobilized collagen (8.6 mg) 
with BSA or IgG (25 nmol/mg collagen) as described above. After filtering and washing, 
0.5  ml of PBS containing 500  #g of 12~I-BSA or  ~2~I-IgG was added to the filter and 
incubated at room temperature for 10 min. This procedure was repeated four times and 
the samples were then washed six times with 1 ml of buffer. The amount of radioactive 
antigen or antibody fixed to the corresponding planted antibody or antigen bound to 
immobilized collagen was determined by counting material retained on the filter. 
Data Analysis.  Statistical  significance of differences observed between paired samples 
were evaluated using Student's t-test. 
Results 
Binding  of Lysine  and  Proteins  to Nonenzymatically  Glycosylated  Collagen.  Incu- 
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agarose 5 M resulted in a nearly fivefold increase in the amount of amino acid 
bound over that observed after incubation with unmodified collagen (Table I). 
The number of nanomoles of radiolabeled amino acid bound to reactive glyco- 
sylated lysine residues in these experiments corresponds to  1.86% of the total 
collagen lysine residues present. This is equivalent to one glucose-derived amino 
group binding site for each 200-rim length of individual tropocollagen molecules 
which, when linked end-to-end and side-to-side, make up the collagen fibril (21). 
The increase in binding of l~SI-serum albumin to nonenzymatically glycosylated 
collagen was very similar in degree to that observed with iysine.  Incubation of 
125I-IgG with nonenzymatically glycosylated collagen resulted in a nearly identical 
number of picomoles being bound.  The  number of glucose-derived reactive 
binding sites cannot be extrapolated from this data, however, since an unknown 
number of lysine residues within the protein may not be accessible. Several lysine 
residues within a  single protein molecule may simultaneously bind at separate 
reactive sites,  and  steric  hinderance by  bound protein  molecules may act  to 
prevent further protein binding. 
In Situ Formation ofhnmune  Complexes.  The ability of antigen (BSA) or anti- 
body (IgG) bound by nonenzymatically glycosylated collagen to form immune 
complexes in situ was established by incubating each with 125I-BSA and with 1~sI-- 
IgG (Table  II).  Nonspecific binding of free ligand (antigen or antibody) was 
evaluated by  incubating each with its  glycosylated-collagen-bound form.  Low 
levels of nonspecific binding were observed in both cases. In contrast, the amount 
of ~SI-antigen (BSA) or t25I-antibody  (IgG) fixed to the corresponding planted 
antibody or antigen bound to glycosylated collagen was strikingly similar to that 
observed in the simple binding experiments described above. 
TABLE  I 
Binding of Lysine and Proteins to Unmodified and Nonenzymatically Glycosylated Collagen* 
Unmodified  Nonenzymatically  NEG-C 
Ligand  collagen (C)  glycosylated  P 
collagen (NEG~)  C 
L-Lysine  0.75 ± 0.23 nmol*  3.49 4. 0.61 nmol  4.65 + 0.17  <0.005 
Serum albumin  45.3 4- 8.1  pmol  172.1 +  13.2 pmol  3.79 4- 0,07  <0.001 
IgG  60.2 ±  13.2 pmol  145 3:13.3 pmol  2.41 + 0.09  <0.005 
* Immobilized calf skin collagen (8.6 rag) was incubated  with either 20 nmol of [14C]-L-lysine or with 1 nmol l~51- 
labeled protein in phosphate buffered saline (3 mM NaNs) at 37°C for 10 d. 
* Values indicate the amount of ligand bound to 1 mg of immobilized calfskin collagen (mean 4. SEM), n = 4. 
TABLE  II 
In Situ Formation of hnmune Complexes by Planted Antigen (BSA) and Planted Antibody (IgG) 
Bound to Nonenzymatically Glycosylated Collagen 
Free antigen or  IgG (anti-BSA) bound to  BSA bound to glycosylated 
antibody  glycosylated collagen*  collagen 
t2SI-BSA  269.7 ± 51.8 pmol*  16.7 4. 9.4 pmol 
t~sI-IgG (anti-BSA)  4.4 ±  13,1 pmol  216.5  + 29.1 pmol 
* Binding of unlabeled  proteins to nonenzymatically  glycosylated collagen was accomplished by incubating  immo- 
bilized calfskin collagen (8.6 rag) with 2.5 mg protein as described  in Table 1. 
* Amount of t~I-antigen (BSA) or t*Sl-antibody (IgG) fixed  to the corresponding planted antibody or antigen 
bound to glycosylated collagen (mean 4- SEM), n = 4. 1742  BROWNLEE  ET  AL.  BRIEF  DEFINITIVE  REPORT 
Discussion 
The reuslts reported in this communication demonstrate that amino acids and 
proteins  are  bound  specifically  by  nonenzymatically glycosylated,  long-lived 
structural proteins such as collagen. Proteins bound in this manner to nonenzy- 
matically glycosylated collagen are able to function as planted antigens or planted 
antibodies in the subsequent in situ formation of immune complexes. 
It should be  noted that the collagen utilized in these experiments, though 
obtained from skin of young animals, undoubtedly had undergone some degree 
of nonenzymatic glycosylation in  vivo before  isolation.  These  nonenzymatic 
glycosylation products could form subsequently the brown pigments that cross- 
link  proteins,  and  could  account  for  the  low  levels  of binding  consistently 
observed with "unmodified" collagen. The nonphysiological glucose concentra- 
tion used in these experiments was selected to accelerate the rate of reactive-site 
formation. In vivo, this process would occur over a much longer period of time, 
consistent with the slow  evolution of clinically demonstrable diabetic vascular 
disease. The concentrations of serum protein used in these experiments were 
considerably less  than those in plasma,  however, a  factor that  would tend to 
reduce the amount of protein bound. 
Previously published immunopathological studies of diabetic  rnicrovascular 
disease in the kidney have demonstrated IgG in a linear pattern resembling that 
seen in anti-basement membrane nephropathy (4,  5).  However, the failure to 
show fixation of IgG from eluates of diabetic kidneys to normal extracellular 
basement membranes in vitro was interpreted as evidence against the participa- 
tion of this type of immunological mechanism in the pathogenesis of diabetic 
microvascular disease. More recently, discontinuous granular ("lumpy-bumpy") 
deposits of immunoglobulins identified by electron microscopy as immune com- 
plexes have been reported in diabetic kidneys (22), and activated-complement, 
(poly C9) membrane-attack complex deposition has also been described (9). Both 
patterns of imrnunoglobulin deposition are consistent with current concepts of 
in situ immune complex formation (6). 
Both the binding of plasma protein constituents to nonenzymaticaUy glyco- 
sylated perivascular structural proteins and their subsequent participation in the 
in  situ  formation of immune complexes may  be  favored  in  vivo by  several 
pathophysiologic and biochemical features of the diabetic state.  The well-de- 
scribed increase in vascular permeability associated with diabetes would result in 
a  higher concentration of extravasated  plasma proteins available  for  binding 
either  primarily,  as  planted antigen  or  antibody,  or  secondarily,  in  immune 
complex formation. Removal of proteins or immune complexes bound to nonen- 
zymatically glycosylated matrix may be reduced due to diabetes-associated defects 
in mesangial clearance mechanisms (23) and perhaps also because of a decreased 
susceptibility to proteolytic degradation associated with nonenzymatic protein 
glycosylation (24). 
The  data  presented in  this  report  suggest that  the chronic tissue  damage 
associated with long-term diabetes meilitus may arise in part from continuous 
accumulation of serum  proteins  and  in  situ  immune complex formation by 
accumulated immunoglobulins and/or antigens bound to long-lived structural 
proteins that have undergone excessive nonenzymatic glycosylation. The essen- BROWNLEE ET  AL.  BRIEF  DEFINITIVE REPORT  1743 
tial  chemical  irreversibility of late  nonenzymatic glycosylation products  once 
formed, together with the extremely long survival times of many structural tissue 
proteins, suggest that therapeutic attempts to normalize blood glucose in diabetic 
patients late in the course of the disease may have little effect on the progression 
of these diabetic complications once they have become clinically manifest. 
Summary 
The chronic tissue damage associated with long-term diabetes mellitus may 
arise in part from in situ immune complex formation by accumulated immuno- 
globulins  and/or  antigens  bound  to  long-lived  structural  proteins  that  have 
undergone excessive nonenzymatic glycosylation. In this report, we have tested 
this hypothesis using nonenzymatically glycosylated collagen.  Binding of both 
albumin and IgG averaged four times the amount bound to unmodified collagen. 
Both albumin and IgG (anti-BSA) bound to nonenzymatically glycosylated col- 
lagen retained their ability to form immune complexes in situ with free antibody 
and antigen. 
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